LENTI, MARCO VINCENZO
 Distribuzione geografica
Continente #
NA - Nord America 2.842
EU - Europa 2.051
AS - Asia 1.093
AF - Africa 7
OC - Oceania 5
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.004
Nazione #
US - Stati Uniti d'America 2.812
IE - Irlanda 980
CN - Cina 796
IT - Italia 486
FI - Finlandia 179
SG - Singapore 175
DE - Germania 151
IN - India 63
SE - Svezia 39
UA - Ucraina 34
FR - Francia 26
BE - Belgio 25
RU - Federazione Russa 24
CA - Canada 23
JP - Giappone 21
GB - Regno Unito 20
RO - Romania 18
CZ - Repubblica Ceca 17
NL - Olanda 11
CH - Svizzera 10
MD - Moldavia 6
AT - Austria 5
AU - Australia 5
ID - Indonesia 5
IL - Israele 5
SA - Arabia Saudita 5
IR - Iran 4
AE - Emirati Arabi Uniti 3
LA - Repubblica Popolare Democratica del Laos 3
LT - Lituania 3
MX - Messico 3
PT - Portogallo 3
SV - El Salvador 3
EG - Egitto 2
ES - Italia 2
ET - Etiopia 2
EU - Europa 2
HK - Hong Kong 2
IM - Isola di Man 2
KG - Kirghizistan 2
MU - Mauritius 2
PE - Perù 2
PL - Polonia 2
RS - Serbia 2
TR - Turchia 2
TW - Taiwan 2
AL - Albania 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
CR - Costa Rica 1
EC - Ecuador 1
EE - Estonia 1
HU - Ungheria 1
IS - Islanda 1
KR - Corea 1
KZ - Kazakistan 1
LV - Lettonia 1
MA - Marocco 1
TM - Turkmenistan 1
VN - Vietnam 1
Totale 6.004
Città #
Dublin 976
Chandler 685
Ashburn 239
Boardman 187
Nanjing 161
Helsinki 155
Shanghai 137
Princeton 134
Lawrence 132
Medford 130
Beijing 120
Singapore 113
Milan 110
New York 96
Wilmington 86
Jacksonville 74
Nanchang 61
Hebei 58
Pune 58
Shenyang 56
Pavia 54
Los Angeles 52
Ann Arbor 49
Changsha 37
Jiaxing 37
Dearborn 36
Munich 26
Brussels 25
Tianjin 25
Hangzhou 22
Fairfield 21
Rome 21
Norwalk 19
Tokyo 19
Woodbridge 19
Seattle 18
Falls Church 17
Guangzhou 17
Toronto 17
Turin 17
Brno 16
Timisoara 16
Chicago 15
Houston 15
Redwood City 14
Washington 13
Dallas 12
Moscow 11
Paris 10
Amsterdam 7
Desio 7
Orange 7
Santa Clara 7
Busto Arsizio 6
Des Moines 6
Falkenstein 6
Rozzano 6
San Francisco 6
Zurich 6
Andover 5
Brescia 5
Caccamo 5
Piscataway 5
Zhengzhou 5
Borås 4
Florence 4
Genova 4
Jinan 4
Menlo Park 4
Naples 4
Palermo 4
Torino 4
Verona 4
Böblingen 3
Chisinau 3
Laives 3
Leawood 3
Melbourne 3
Ningbo 3
Ottawa 3
Paceco 3
Padova 3
Ramat Gan 3
San Salvador 3
Vientiane 3
Addis Ababa 2
Ankara 2
Bad Sobernheim 2
Bangalore 2
Belgrade 2
Biassono 2
Bientina 2
Bishkek 2
Bologna 2
Borgomanero 2
Buffalo 2
Cagliari 2
Cairo 2
Cambridge 2
Camponogara 2
Totale 4.629
Nome #
Impaired respiratory function reduces haemoglobin oxygen affinity in COVID-19 147
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly. 82
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 75
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 73
A consensus for the development of a vector model to assess clinical complexity 73
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 68
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 68
Correction to: Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy (Internal and Emergency Medicine, (2020), 15, 8, (1457-1465), 10.1007/s11739-020-02493-y) 66
A laboratory score in the diagnosis of autoimmune atrophic gastritis: A prospective study 63
Correction to: Anemia in patients with Covid-19: pathogenesis and clinical significance (Clinical and Experimental Medicine, (2021), 10.1007/s10238-020-00679-4) 63
Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy 61
Depletion of circulating IgM memory B cells predicts unfavourable outcome in COVID-19 61
Infertility and recurrent miscarriage in a patient with autoimmune atrophic gastritis 60
Acute kidney injury caused by COVID-19 in a patient with Crohn's disease treated with adalimumab 60
Vaccination coverage and mortality after splenectomy: results from an Italian single-centre study 58
Association between defective spleen function and primary eosinophilic gastrointestinal disorders 58
Increase in chromogranin A- and serotonin-positive cells in pouch mucosa of patients with ulcerative colitis undergoing proctocolectomy 58
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 57
Common features of patients with autoimmune atrophic gastritis. 56
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 55
Diagnostic delay in adult coeliac disease: An Italian multicentre study 54
Detection of Active Epstein-Barr Virus Infection in Duodenal Mucosa of Patients With Refractory Celiac Disease 54
Clinical usefulness of serum antibodies as biomarkers of gastrointestinal and liver diseases 54
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study 54
Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy 54
Acquired von Willebrand syndrome in inflammatory bowel disease 53
Defective spleen function in autoimmune gastrointestinal disorders 53
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 53
Abnormal post-prandial glucagon-like peptide release in patients with Crohn's disease 53
Diagnostic Delay of Pulmonary Embolism in COVID-19 Patients 53
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 52
The Italian Society of Internal Medicine choosing wisely campaign 51
Determinants of diagnostic delay in autoimmune atrophic gastritis 51
Small bowel adenocarcinomas featuring special at-rich sequence-binding protein 2 (Satb2) expression and a colorectal cancer-like immunophenotype: A potential diagnostic pitfall 51
Reflux symptoms in professional opera soloists 49
Poorly Cohesive Carcinoma of the Nonampullary Small Intestine: A Distinct Histologic Subtype with Prognostic Significance 49
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 48
Preventing Infections by Encapsulated Bacteria Through Vaccine Prophylaxis in Inflammatory Bowel Disease 48
Controlling Gut Inflammation by Restoring Anti-Inflammatory Pathways in Inflammatory Bowel Disease 47
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 47
The time course of diagnostic delay in inflammatory bowel disease over the last sixty years: An Italian multicentre study 46
PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability 46
Anemia in patients with Covid-19: pathogenesis and clinical significance 46
QTc Interval and Mortality in a Population of SARS-2-CoV Infected Patients 45
Autoimmune diseases associated with common variable immune deficiency 45
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 45
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation 44
Cell Blood Count Alterations and Patterns of Anaemia in Autoimmune Atrophic Gastritis at Diagnosis: A Multicentre Study 44
Administrative data for exploring multimorbidity in hospitalised patients 44
Upper gastrointestinal bleeding in COVID-19 inpatients: Incidence and management in a multicenter experience from Northern Italy 44
Prognostic Role of Mismatch Repair Status, Histotype and High-Risk Pathologic Features in Stage II Small Bowel Adenocarcinomas 44
Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study 43
Clinical and gastro-duodenal histopathological features of enteropathy due to angiotensin II receptor blockers 43
New insights into immune mechanisms underlying autoimmune diseases of the gastrointestinal tract 42
Natural history of autoimmune atrophic gastritis: a prospective, single centre, long-term experience 42
Safety and durability of PEG-J: a single-centre experience 42
Incidence and risk factors for preneoplastic and neoplastic lesions of the colon and rectum in patients under 50 referred for colonoscopy 42
Seronegative autoimmune diseases: A challenging diagnosis 41
Medication non-adherence in adult patients affected by inflammatory bowel disease: a critical review and update of the determining factors, consequences and possible interventions 41
Editorial: determinants of diagnostic delay in autoimmune atrophic gastritis-a salutary lesson. Authors' reply 41
Correction: PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability 41
Separation of low versus high grade Crohn's disease-associated small bowel carcinomas is improved by invasive front prognostic marker analysis 40
Histologic heterogeneity and syndromic associations of non-ampullary duodenal polyps and superficial mucosal lesions 40
COVID-19-related symptom clustering in a primary care vs internal medicine setting 40
Impact of COVID-19 in immunosuppressive drug-naïve autoimmune disorders: Autoimmune gastritis, celiac disease, type 1 diabetes, and autoimmune thyroid disease 40
Multidimensional Prognostic Index Predicts Clinical Outcome and Mortality in Hospitalised Older Patients with Diverticular Disease 40
Diet Therapy in Eosinophilic Esophagitis. Focus on a Personalized Approach 40
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 39
Bringing complexity into clinical practice: An internistic approach 39
Chronic atrophic gastritis: Natural history, diagnosis and therapeutic management. A position paper by the Italian Society of Hospital Gastroenterologists and Digestive Endoscopists [AIGO], the Italian Society of Digestive Endoscopy [SIED], the Italian Society of Gastroenterology [SIGE], and the Italian Society of Internal Medicine [SIMI] 39
Rectal neuroendocrine cell proliferation in a patient with ulcerative colitis treated with adalimumab 39
The challenging diagnosis of autoimmune atrophic gastritis 38
Serum markers of refractoriness and enteropathy-associated t-cell lymphoma in coeliac disease 38
Lower incidence of COVID-19 in patients with inflammatory bowel disease treated with non-gut selective biologic therapy 38
Reproducibility in the Assessment of the Components of a Clinical Complexity Index 37
Validation of the Red Flags Index for Early Diagnosis of Crohn's Disease: A Prospective Observational IG-IBD Study Among General Practitioners 37
Aging underlies heterogeneity between comorbidity and multimorbidity frameworks 37
Trusting internal medicine in hard times 36
Nivolumab-associated active neutrophilic gastritis 36
Resilience is associated with frailty and older age in hospitalised patients 35
Clinical complexity and hospital admissions in the December holiday period 35
Prognostic relevance and putative histogenetic role of cytokeratin 7 and MUC5AC expression in Crohn’s disease-associated small bowel carcinoma 35
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 35
A real-world, long-term experience on effectiveness and safety of vedolizumab in adult patients with inflammatory bowel disease: The Cross Pennine study 34
Malabsorption and malabsorption tests: Do they still matter? 33
Does biopsy still have a role for adult coeliac disease? 33
Are we choosing wisely for inflammatory bowel disease care? The IG-IBD choosing wisely campaign 33
Extent of Mucosal Inflammation in Ulcerative Colitis Influences the Clinical Remission Induced by Vedolizumab 33
High prevalence of acute stress disorder and persisting symptoms in ICU survivors after COVID-19 33
Global Meta-Analysis on the Association between Behcet Syndrome and Polymorphisms from the HLA Class I (A, B, and C) and Class II (DRB1, DQB1, and DPB1) Genes 33
Increase of Deep Intraepithelial Lymphocytes in the Oxyntic Mucosa of Patients With Potential and Overt Autoimmune Gastritis 32
Evaluation of diagnostic time in pediatric patients with eosinophilic gastrointestinal disorders according to their clinical features 32
How to predict response to anti-tumour necrosis factor agents in inflammatory bowel disease 32
Early-onset versus late-onset Crohn's disease: An Italian cohort study 32
From sadness to stiffness: the spleen’s progress 32
Impaired Quality of Life in Patients with Autoimmune Atrophic Gastritis 32
Validation of the Italian translation of the perceived stigma scale and resilience assessment in inflammatory bowel disease patients 32
Allergic manifestations in autoimmune gastrointestinal disorders 32
Therapeutic Targeting of Intestinal Fibrosis in Crohn’s Disease 32
The stigma of low opioid prescription in the hospitalized multimorbid elderly in Italy 31
Totale 4.685
Categoria #
all - tutte 39.810
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.810


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020268 0 0 0 0 0 17 27 22 17 48 55 82
2020/2021250 11 29 8 11 13 41 3 65 14 32 14 9
2021/2022657 5 3 27 6 12 16 11 77 43 32 72 353
2022/20232.320 206 177 20 134 147 212 43 123 1.131 29 73 25
2023/20241.313 116 195 38 70 163 305 122 86 15 74 60 69
2024/2025747 92 212 110 190 132 11 0 0 0 0 0 0
Totale 6.369